Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Carcinogenesis

• Publication date

  1990-04-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1093/CARCIN/11.4.673PMID 2323006
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosomes and chromosomal evolution in human mesotheliomas as reflected in sequential analyses of two cases.

  2008cited by this paper
• Mineral fiber concentration in lung tissue of mesothelioma patients in Finland.

  1989cited by this paper
• Nonrandom chromosomal abnormalities in malignant pleural mesothelioma.

  1988cited by this paper
• Nonrandom chromosome alterations in human malignant mesothelioma.

  1988cited by this paper
• Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

  1988cited by this paper
• Establishment of human mesothelioma cell lines (MS-1, -2) and production of a monoclonal antibody (anti-MS) with diagnostic and therapeutic potential.

  1988cited by this paper
• Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study.

  1987cited by this paper
• Production of reactive oxygen metabolites induced by asbestos fibres in human polymorphonuclear leucocytes.

  1987cited by this paper
• Involvement of chromosome 7 in primary lung tumor and nonmalignant normal lung tissue.

  1987cited by this paper
• Cytogenetic findings in an effusion secondary from pleural mesothelioma.

  1987cited by this paper
• Loss of heterozygosity of chromosome 3p markers in small-cell lung cancer

  1987cited by this paper
• Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer

  1987cited by this paper
• Comparison of production of transforming growth factor-beta and platelet-derived growth factor by normal human mesothelial cells and mesothelioma cell lines.

  1987cited by this paper
• The cytogenetics of solid tumors. Relation to diagnosis, classification and pathology

  1987cited by this paper
• Nineteen of 26 cellular oncogenes precisely localized in the human genome map to one of the 83 bands involved in primary cancer-specific rearrangements

  1987cited by this paper
• Characterization of a human malignant mesothelioma cell line (H-MESO-1): a biphasic solid and ascitic tumor model.

  1987cited by this paper
• Deletions of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein.

  1987cited by this paper
• Chromosome changes in malignant mesothelioma.

  1986cited by this paper
• cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines

  1986cited by this paper
• Diagnosis of pleural malignant mesothelioma in life—a practical approach

  1984cited by this paper
• Chromosome changes in soft tissue sarcomas.

  1984cited by this paper
• The chromosomal basis of human neoplasia.

  1983cited by this paper
• Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

  1983cited by this paper
• A chromosomal hypothesis of oncogenesis.

  1983cited by this paper
• Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells.

  1982cited by this paper
• Specific chromosome defect associated with human small-cell lung cancer; deletion 3p(14-23).

  1982cited by this paper
• Monosomy 14, monosomy 22 and 13q--three chromosomal abnormalities observed in cells of two malignant mesotheliomas studied by banding techniques.

  1978cited by this paper
• Nonspecific acid esterase activity: A criterion for differentation of T and B lymphocytes in mouse lymph nodes

  1975cited by this paper
• A simple technique for demonstrating centromeric heterochromatin.

  1972cited by this paper
• A rapid banding technique for human chromosomes.

  1971cited by this paper

• Cytoskeletal Organization Correlates to Motility and Invasiveness of Malignant Mesothelioma Cells

  2021cites this paper
• Use of preclinical models for malignant pleural mesothelioma

  2021cites this paper
• In vitro and in vivo laboratory models of pleural disease

  2020cites this paper
• Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy

  2018cites this paper
• Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions

  2014cites this paper
• Characterization of malignant pleural mesothelioma : possibilities for an individualized therapeutic arsenal

  2014cites this paper
• A method to visualize the uncertainty of the prediction of radiobiological models.

  2013cites this paper
• Phenotypes and Karyotypes of Human Malignant Mesothelioma Cell Lines

  2013cites this paper
• Variation in Drug Sensitivity of Malignant Mesothelioma Cell Lines with Substantial Effects of Selenite and Bortezomib, Highlights Need for Individualized Therapy

  2013cites this paper
• M14K and M38K malignant pleural mesothelioma cell lines preserve the same claudin-based phenotype in vivo.

  2013cites this paper
• Molecular Resistance Fingerprint of Pemetrexed and Platinum in a Long-Term Survivor of Mesothelioma

  2012cites this paper
• Combined chemotherapy with cytotoxic and targeted compounds for the management of human malignant pleural mesothelioma.

  2011cites this paper
• Latent TGF-β binding proteins (LTBPs) 1 and 3 differentially regulate transforming growth factor-β activity in malignant mesothelioma.

  2011cites this paper
• Molecular profiling of malignant pleural mesothelioma and pulmonary fibrosis

  2009cites this paper
• Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

  2009cites this paper
• Expression of GATA-6 transcription factor in pleural malignant mesothelioma and metastatic pulmonary adenocarcinoma

  2008cites this paper
• Establishment and characterization of two distinct malignant mesothelioma cell lines with common clonal origin.

  2007cites this paper
• Cytogenetic and molecular genetic changes in malignant mesothelioma.

  2006cites this paper
• Advances in Brief p 53 and Kirsten-ras Mutations in Human Mesothelioma Cell Lines

  2006cites this paper
• NITRIC OXIDE SYNTHASES AND REACTIVE OXYGEN SPECIES DAMAGE IN PLEURAL AND LUNG TISSUES AND NEOPLASIA

  2005cites this paper
• Mesothelial and Mesothelioma Cell Lines

  2005cites this paper
• MATRIX METALLOPROTEASES AND CELL MOTILITY IN MALIGNANT MESOTHELIOMA

  2004cites this paper
• Chemotaxis and chemokinesis of malignant mesothelioma cells to multiple growth factors.

  2004cites this paper
• Ultrastructural and chromosomal studies on manganese superoxide dismutase in malignant mesothelioma.

  2004cites this paper
• Inhibition of proliferation, migration, and matrix metalloprotease production in malignant mesothelioma cells by tyrosine kinase inhibitors.

  2004cites this paper
• Reduced Fhit protein expression in human malignant mesothelioma

  2004cites this paper
• Expression of hyaluronan synthases and hyaluronan in malignant mesothelioma cells.

  2004cites this paper
• Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium

  2003cites this paper
• Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region.

  2002cites this paper
• Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma

  2002cites this paper
• Overexpression of γ-glutamylcysteine synthetase in human malignant mesothelioma

  2002cites this paper
• Overexpression of gamma-glutamylcysteine synthetase in human malignant mesothelioma.

  2002cites this paper
• Endothelial nitric oxide synthase is strongly expressed in malignant mesothelioma but does not associate with vascular density or the expression of VEGF, FLK1 or FLT1

  2001cites this paper
• Expression and prognostic significance of catalase in malignant mesothelioma

  2001cites this paper
• Antioxidant enzymes and related mechanisms in malignant pleural mesothelioma

  2001cites this paper
• Widespread expression of thioredoxin and thioredoxin reductase in non-small cell lung carcinoma.

  2001cites this paper
• Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma.

  2001cites this paper
• Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines

  2001cites this paper
• Up‐regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma

  2001cites this paper
• Gene expression profiling of malignant mesothelioma cell lines: cDNA array study

  2001cites this paper
• Toxicological profile for asbestos

  2001cites this paper
• Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma

  2000cites this paper
• Expression of inducible nitric oxide synthase in healthy pleura and in malignant mesothelioma

  2000cites this paper
• Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma

  2000cites this paper
• In vitro sensitivity of normal human mesothelial and malignant mesothelioma cell lines to four new chemotherapeutic agents

  2000cites this paper
• Antioxidant defense mechanisms of human mesothelioma and lung adenocarcinoma cells.

  2000cites this paper
• Generation of reactive oxygen species by human mesothelioma cells

  1999cites this paper
• Asbestos induction of extended lifespan in normal human mesothelial cells: interindividual susceptibility and SV40 T antigen.

  1999cites this paper
• The expression and possible role of manganese superoxide dismutase in malignant pleural mesothelioma

  1999cites this paper
• Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma.

  1999cites this paper
• Platelet-derived growth factor (PDGF) BB acts as achemoattractant for human malignant mesotheliomacells via PDGF receptor b - integrin a3b1 interaction

  1998cites this paper
• Hepatocyte growth factor/scatter factor stimulates chemotaxis and growth of malignant mesothelioma cells through c‐met receptor

  1998cites this paper
• Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma.

  1998cites this paper
• Platelet-derived growth factor (PDGF) BB acts as a chemoattractant for human malignant mesothelioma cells via PDGF receptor beta-integrin alpha3beta1 interaction.

  1998cites this paper
• Tenascin and fibronectin expression in human mesothelial cells and pleural mesothelioma cell-line cells.

  1998cites this paper
• Endogenous antioxidant enzymes and glutathione S-transferase in protection of mesothelioma cells against hydrogen peroxide and epirubicin toxicity.

  1998cites this paper
• Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: The role of β1 integrins

  1997cites this paper
• Induction of micronuclei, hyperdiploidy and chromosomal breakage affecting the centric/pericentric regions of chromosomes 1 and 9 in human amniotic fluid cells after treatment with asbestos and ceramic fibers.

  1997cites this paper
• Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma.

  1997cites this paper
• The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.

  1996cites this paper
• Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization.

  1996cites this paper
• Radiosensitivity of mesothelioma cell lines.

  1996cites this paper
• In vitro and in vivo studies of mesothelioma

  1996cites this paper
• Manganese superoxide dismutase in human pleural mesothelioma cell lines.

  1996cites this paper
• Interferon (IFN)-alpha and IFN-gamma in combination with methotrexate: in vitro sensitivity studies in four human mesothelioma cell lines.

  1995cites this paper
• Lung carcinoma and malignant mesothelioma in patients exposed to thorotrast: Incidence, histology and p53 status

  1995cites this paper
• Effects of asbestos and man‐made vitreous fibers on cell division in cultured human mesothelial cells in comparison to rodent cells

  1995cites this paper
• Interferon and lung cancer.

  1995cites this paper
• Establishment and characterization of a new human mesothelioma cell line (T‐85) from malignant peritoneal mesothelioma with remarkable thrombocytosis

  1995cites this paper
• Asbestos and the mesothelial cell: a molecular trail to mitogenic stimuli and suppressor gene suspects.

  1994cites this paper
• Cellular and molecular mechanisms of asbestos carcinogenicity: implications for biopersistence.

  1994cites this paper
• Mutations and altered expression of p16INK4 in human cancer.

  1994cites this paper
• p16INK4 mutations and altered expression in human tumors and cell lines.

  1994cites this paper
• Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells.

  1994cites this paper
• Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.

  1994cites this paper
• Malignant pleural mesothelioma.

  1993cites this paper
• Karyotypic changes in the preclinical and subsequent stages of malignant mesothelioma: a case report.

  1993cites this paper
• Tumorigenic conversion of human mesothelial cells as a consequence of platelet-derived growth factor-A chain overexpression.

  1993cites this paper
• Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells.

  1993cites this paper
• Malignant mesothelioma: clinical characteristics, asbestos mineralogy and chromosomal abnormalities of 41 patients.

  1992cites this paper
• Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: Interleukin‐6 production as a common feature

  1992cites this paper
• p53 and Kirsten-ras mutations in human mesothelioma cell lines.

  1992cites this paper
• Interferon-alpha and -gamma in combination with chemotherapeutic drugs: in vitro sensitivity studies in four human mesothelioma cell lines.

  1992cites this paper
• Possible cellular and molecular mechanisms for asbestos carcinogenicity.

  1992cites this paper
• Comparison of DNA and karyotype ploidy in malignant mesothelioma.

  1992cites this paper
• An autocrine mitogenic activity produced by a pleural human mesothelioma cell line

  1992cites this paper
• CHROMOSOMAL DAMAGE AND GAP JUNCTIONAL INTERCELLULAR COMMUNICATION IN MESOTHELIOMA CELL LINES AND CULTURED HUMAN PRIMARY MESOTHELIAL CELLS TREATED WITH MMMF

  1991cites this paper
• Tumour markers and oncogenes in lung cancer.

  1991cites this paper
• Trisomy of rat chromosome 1 associated with mesothelial cell transformation.

  1991cites this paper
• Malignant mesothelioma: the antiproliferative effect of cytokine combinations on three human mesothelioma cell lines.

  1991cites this paper
• Diploid predominance and prognostic significance of S-phase cells in malignant mesothelioma.

  1991cites this paper
• Hereditary renal cell carcinoma in the rat associated with nonrandom loss of chromosomes 5 and 6.

  1991cites this paper